|« Previous month|
19-Jan-2017 - The next-generation wireless glucometer provides rapid testing results on the company’s eCOA platform for clinical trials.
19-Jan-2017 - EAG Laboratories has added dermal absorption studies to its GLP-compliant testing services suite, as part of the company’s plan to continue expanding its capabilities.
19-Jan-2017 - The HHS issued a final rule updating outdated regulations to provide enhanced protection for clinical research participants – and the FDA may follow suit.
18-Jan-2017 - AXIM Biotechnologies, Inc. will start 40-person clinical trial in the Netherlands for a mint-flavoured medical marijuana chewing gum to treat Irritable bowel syndrome (IBS).
18-Jan-2017 - Servier has recruited CDMO MaSTherCell SA to manufacture its universal CAR-T candidate UCART19, licensed from the biotech Cellectis as an off-the-shelf cell therapy for leukemia.
18-Jan-2017 - CROS NT has opened a new office in Bangalore, India as it looks to expand its clinical, regulatory, and data services lines to meet client demand.
18-Jan-2017 - Evotec AG and MaRS Innovation have launched Fibrocor Therapeutics LP – a new company which will focus on developing first-in-class therapeutics targeting fibrotic diseases.
18-Jan-2017 - A pool of contractors will compete for task orders as part of the NIAID's preclinical drug development services contract to develop therapeutics for a range of global infectious diseases.
17-Jan-2017 - The distribution giant, McKesson Corporation, has agreed to pay the DEA's record fine of $150m after allegedly failing to report “suspicious orders” for controlled substances.
17-Jan-2017 - Technology is catapulting clinical trials into a 'new era' as scientific breakthroughs bring new opportunities to an industry that has traditionally lacked innovation.
17-Jan-2017 - Exco InTouch has formally received certification demonstrating it meets certain data privacy and security principles.
17-Jan-2017 - The Chapel Hill, NC-based contract research organization (CRO) has implemented PhlexEview4 as its preferred eTMF solution to support commercial and government clients.
17-Jan-2017 - Horizon Discovery Group has extended its CRISPR technology license to improve the performance of CHO cell lines for biomanufacturing.
16-Jan-2017 - Poor communication between healthcare providers and clinical research professionals is contributing to low recruitment rates, according to a recent study by Tufts.
16-Jan-2017 - GSK has renewed an environmental monitoring contract with Exova across manufacturing sites in the UK and Ireland.
16-Jan-2017 - Helomics has signed a deal with the diagnostics firm MDNA Life Sciences Inc., to help further develop MDNA’s liquid biopsy platform and commercialize its tests for prostate cancer.
12-Jan-2017 - FUJIFILM Diosynth Biotechnologies USA (FDBU) has selected SciQuest to automate ‘critical’ purchasing and accounts payable processes.
12-Jan-2017 - The asset acquisition adds seven patient service centers to LabCorps’ network of 120 patient service centers in the metropolitan New York City area.
12-Jan-2017 - The “NCI Formulary” enables investigators to obtain investigational agents for testing in new preclinical or clinical studies.
12-Jan-2017 - The updated Simcyp Simulator features several enhanced models to help predict pharmacokinetic outcomes in virtual patient populations.
11-Jan-2017 - Aerie Pharmaceuticals Inc will lease a 30,000 sq ft manufacturing facility in Ireland to commercialise its eye-drop product for Glaucoma after delays at a third party CMO.
11-Jan-2017 - Ferring Pharmaceuticals has selected endpoint as its sole leading interactive response technology (IRT) provider.
11-Jan-2017 - Catalent will assess Jupiter Orphan Therapeutics’ resveratrol across its softgel technologies in an effort to improve the bioavailability of the rare disease candidate.
11-Jan-2017 - Parexel’s restructuring plan to ‘simplify the organization’ will include eliminating an undisclosed amount of positions as the CRO looks to save on costs.
11-Jan-2017 - Pharmaron’s acquisition of Xceleron further supports early discovery, preclinical and clinical development with expanded radiolabeled sciences capabilities.
|« Previous month|